Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

A doctor has issued an warning as to why Ozempic shouldn't be used for weight loss as it does one alarming thing to body.

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

As more people take GLP-1 medications for weight loss, dietitians are seeing their appointments booked out for months. Channel 2’s Lori Wilson got some advice from a Piedmont Healthcare dietitian who ...

The result means those using the medication should feel less hungry more often and fuller for longer. Ozempic is the brand name for semaglutide, which is the active ingredient in several weight loss ...

Initially developed to assist people with type 2 diabetes, semaglutides have gained popularity as a weight loss drug ... that when she started taking the medication, she felt a sense of shame ...

examples are semaglutide and tirzepatide, which work in the brain to impact satiety. GLP-1 medications have become trendy tools for weight loss, however, Smith claimed the most noticeable thing ...

“As we age, one of the biggest killers is the loss of metabolic control, which is seen in an increase in blood sugar, despite an increase in insulin,” Perricone wrote. Perricone believes that ...

The telemedicine entities Lilly are suing are Willow Health Services, Adonis Health (d/b/a Henry Meds), Mochi Health ... rival Novo Nordisk's (NVO) GLP-1, semaglutide, sold as Ozempic for diabetes ...